GENEREX BIOTECHNOLOGY CORP
GENEREX BIOTECHNOLOGY CORP (GNBT) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 55 transactions totaling $782.7K, demonstrating a bearish sentiment with -$124.2K in net insider flow. The most recent transaction on Nov 16, 2019 involved a purchase of 10,000 shares valued at $5.1K.
GNBT Insider Activity Summary
Who Is Buying GNBT Stock?
No significant insider buying has been recorded for GNBT in the recent period.
Who Is Selling GNBT Stock?
No significant insider selling has been recorded for GNBT in the recent period.
Is GENEREX BIOTECHNOLOGY CORP Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GNBT is bearish with an Insider Alignment Score of 42/100 and a net flow of -$124.2K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
GNBT Frequently Asked Questions
Understanding GNBT Insider Activity
Insider trading at GENEREX BIOTECHNOLOGY CORP (GNBT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading GNBT stock, having executed 55 transactions in the past 90 days. The most active insider is Mark Fletcher (Executive), who has made 14 transactions totaling $513.1K.
Related Tools
Track GENEREX BIOTECHNOLOGY CORP Insider Activity
Get notified when executives and directors at GNBT file new Form 4 transactions